Reply to: "Commentary on Beldman et al. : If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicenter observational study"

被引：0
|
作者：
Wouthuyzen-Bakker, Marjan [1 ]
机构：
[1] Univ Med Ctr Groningen, Groningen, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 04期
关键词：
D O I：
10.1093/cid/ciac215
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：740 / 740
页数：1
相关论文
共 29 条
  • [1] If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
    Beldman, Mark
    Lowik, Claudia
    Soriano, Alex
    Albiach, Laila
    Zijlstra, Wierd P.
    Knobben, Bas A. S.
    Jutte, Paul
    Sousa, Ricardo
    Carvalho, Andre
    Goswami, Karan
    Parvizi, Javad
    Belden, Katherine A.
    Wouthuyzen-Bakker, Marjan
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : 1634 - 1641
  • [2] If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study (vol 3, pg 1634, 2021)
    Beldman, Mark
    Lowik, Claudia
    Soriano, Alex
    Albiach, Laila
    Zijlstra, Wierd P.
    Knobben, Bas A. S.
    Jutte, Paul
    Sousa, Ricardo
    Carvalho, Andre
    Goswami, Karan
    Parvizi, Javad
    Belden, Katherine A.
    Wouthuyzen-Bakker, Marjan
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 74 (10) : 1890 - 1890
  • [3] Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
    Leijtens, Borg
    Elbers, Joris B. W.
    Sturm, Patrick D.
    Kullberg, Bart Jan
    Schreurs, Berend W.
    [J]. BMC INFECTIOUS DISEASES, 2017, 17
  • [4] Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
    Borg Leijtens
    Joris B. W. Elbers
    Patrick D. Sturm
    Bart Jan Kullberg
    Berend W. Schreurs
    [J]. BMC Infectious Diseases, 17
  • [5] RE: Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study by Kramer et al.
    Rieber, Heime
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (03):
  • [6] Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study
    Kramer, Tobias Siegfried
    Soriano, Alex
    Tedeschi, Sarah
    Chen, Antonia F.
    Tattevin, Pierre
    Senneville, Eric
    Gomez-Junyent, Joan
    Birlutiu, Victoria
    Petersdorf, Sabine
    de Brito, Vicens Diaz
    Gonzalez, Ignacio Sancho
    Belden, Katherine A.
    Wouthuyzen-Bakker, Marjan
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (03):
  • [7] Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been Exchanged? A Multicenter Observational Cohort Study
    Kramer, Tobias Siegfried
    Soriano, Alex
    Tedeschi, Sarah
    Chen, Antonia F.
    Tattevin, Pierre
    Senneville, Eric
    Gomez-Junyent, Joan
    Birlutiu, Victoria
    Petersdorf, Sabine
    de Brito, Vicens Diaz
    Gonzalez, Ignacio Sancho
    Belden, Katherine A.
    Wouthuyzen-Bakker, Marjan
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (10):
  • [8] Is It the Time for Universal Joint Aspiration in the Case of Periprosthetic Joint Infection? Commentary on an article by Darius M. Thiesen, MD, et al.: "Synchronous Periprosthetic Joint Infections. The Need for All Artificial Joints to Be Aspirated Routinely"
    Zhu Junjun
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (04):
  • [9] Is It Time to Consider Single-Stage Revision for Periprosthetic Joint Infections After Total Knee Replacement? Commentary on an article by Louis Dagneaux, MD, et al.: "Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers. Incidence, Risks, and Outcomes"
    Randsborg, Per-Henrik
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2021, 103 (09):
  • [10] Reply to comment on: Haubitz et al. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study
    Sebastian, Haubitz
    Fux, Christoph A.
    [J]. SWISS MEDICAL WEEKLY, 2021, 151
123